American Society of Hematology

SHERPA: Blue

People

  1. Schoder
    Schoder
  2. Noy
    Noy
  3. Zelenetz
    Zelenetz
  4. Moskowitz
    Moskowitz
  5. Palomba
    Palomba
  6. Horwitz
    Horwitz
  7. Hamlin
    Hamlin
  8. Yahalom
    Yahalom
  9. Kumar
    Kumar
  10. Caron
    Caron

Groups

  1. Molecular Imaging and Therapy Service (61)
  2. Radiology, Department of (61)
  3. Center for Hematologic Malignancies (51)
  4. Department of Medicine (51)
  5. Hematologic Malignancies, Division of (51)
  6. Lymphoma (51)
  7. Survivorship Research (30)
  8. Population Sciences Research Program (22)
  9. Radiation Oncology, Department of (20)
  10. Epidemiology and Biostatistics (19)
Search Within
  1. "Radiology, Department of"
  2. "Heiko Schoder"
Formats
  1. Meeting Abstract (43)
  2. Journal Article (18)
Groups
  1. Molecular Imaging and Therapy Service (61)
  2. Radiology, Department of (61)
  3. Center for Hematologic Malignancies (51)
  4. Department of Medicine (51)
  5. Hematologic Malignancies, Division of (51)
  6. Lymphoma (51)

More Groups

People
  1. Heiko Schoder (61)
  2. David Straus (29)
  3. Andrew Zelenetz (27)
  4. Ariela Noy (27)
  5. Alison Moskowitz (26)
  6. Maria Palomba (23)

More People

Years
  1. 2023 (7)
  2. 2022 (3)
  3. 2021 (7)
  4. 2020 (5)
  5. 2019 (9)
  6. 2018 (6)

More Years

Publications
  1. Blood (57)
  2. Blood Advances (4)

Results (61)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • AHOD2131: A randomized phase 3 response-adapted trial comparing standard therapy with immuno-oncology therapy for children and adults with newly diagnosed stage I and II classic Hodgkin lymphoma
    Meeting Abstract

    Henderson, T. O.; Hu, B.; Keller, F.; Pei, Q.; Wu, Y.; Hoppe, B.; Milgrom, S.; Yao, S.; Khan, N.; Roth, L. G.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Impact of early histological transformation on survival in patients with follicular lymphoma
    Journal Article

    Luttwak, E.; Qiu, A.; Okwali, M.; Rivas-Delgado, A.; Isgor, I.; Boardman, A. P.; Caron, P.; David, K. A.; Falchi, L.; Ghione, P.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Dynamics of radiomic features following bridging therapy determine CD19 chimeric antigen receptor (CAR) T-cell therapy outcome
    Meeting Abstract

    Hubbeling, H.; Leithner, D.; Silverman, E. A.; Flynn, J. R.; Devlin, S. M.; Shah, G. L.; Fregonese, B.; Bedmutha, A.; Wills, B.; Tomas, A. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Distinct patterns of CD4+and CD8+ T-cell clonal expansion enable broad clinical responses to pembrolizumab + GVD in patients with relapsed Hodgkin lymphoma
    Meeting Abstract

    Wills, B.; Rahman, J.; Ganesan, N.; Shah, G. L.; Noy, A.; Schoder, H.; Yahalom, J.; Kumar, A.; Falchi, L.; Hamlin, P. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A phase I study of CD19-targeted 19(T2)28z1xx CAR T cells in adult patients with relapsed or refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Park, J. H.; Palomba, M. L.; Devlin, S. M.; Valtis, Y. K.; Sikder, D. S.; Senechal, B.; Wang, X.; Cathcart, E.; Liotta, K.; Yu, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • 18F-FDG PET/CT imaging biomarkers for car-T cell therapy outcomes in large-B-cell lymphoma
    Meeting Abstract

    Leithner, D.; Flynn, J. R.; Devlin, S. M.; Mauguen, A.; Fei, T.; Zeng, S.; Imber, B. S.; Hubbeling, H.; Mayerhoefer, M.; Luttwak, E.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Retrospective characterization of nodal marginal zone lymphoma
    Journal Article

    Stuver, R.; Drill, E.; Qualls, D.; Okwali, M.; Batlevi, C. L.; Caron, P. C.; Dogan, A.; Epstein-Peterson, Z. D.; Falchi, L.; Hamlin, P. A.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Immune signature of pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Meeting Abstract

    Wills, B.; Ganesan, N.; Shah, G. L.; Wong, P.; Argyropoulos, K. V.; Sen, F.; Dogan, A.; Straus, D. J.; Noy, A.; Kumar, A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Correlative biomarkers for CART19 response in patients with relapsed or refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Batlevi, C. L.; Nos, G.; Kotlov, N.; Sorokina, M.; Okwali, M.; Bagaev, A.; Michaud, L.; Shah, G. L.; Shouval, R.; Tomas, A. A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Brentuximab vedotin combined with chemotherapy in newly diagnosed, early-stage, unfavorable-risk Hodgkin lymphoma: Extended follow-up with evaluation of baseline metabolic tumor volume and PET2
    Meeting Abstract

    Stuver, R.; Michaud, L.; Casulo, C.; Advani, R. H.; Budde, E. L.; Barr, P. M.; Batlevi, C. L.; Caron, P. C.; Constine, L. S.; Dandapani, S.; more...
    Blood (2022)

    Fulltext@MSK | Save